TuHURA Biosciences, Inc. (HURA)
2.05
-0.08
(-3.76%)
USD |
NASDAQ |
Sep 23, 16:00
2.05
0.00 (0.00%)
Pre-Market: 09:08
TuHURA Biosciences Total Assets (Quarterly) : 31.75M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.75M |
| March 31, 2026 | 29.70M |
| December 31, 2025 | 27.35M |
| September 30, 2025 | 25.70M |
| June 30, 2025 | 34.62M |
| March 31, 2025 | 14.64M |
| December 31, 2024 | 19.97M |
| September 30, 2024 | 27.11M |
| June 30, 2024 | 6.202M |
| March 31, 2024 | 7.446M |
| December 31, 2023 | 1.885M |
| September 30, 2023 | 1.477M |
| June 30, 2023 | 3.979M |
| March 31, 2023 | 6.74M |
| December 31, 2022 | 9.917M |
| September 30, 2022 | 13.21M |
| June 30, 2022 | 15.95M |
| March 31, 2022 | 12.80M |
| December 31, 2021 | 17.72M |
| September 30, 2021 | 22.34M |
| June 30, 2021 | 13.54M |
| March 31, 2021 | 18.85M |
| December 31, 2020 | 20.49M |
| September 30, 2020 | 23.13M |
| June 30, 2020 | 2.938M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.102M |
| December 31, 2019 | 6.508M |
| September 30, 2019 | 8.364M |
| June 30, 2019 | 4.037M |
| March 31, 2019 | 2.457M |
| December 31, 2018 | 4.038M |
| September 30, 2018 | 4.750M |
| June 30, 2018 | 7.075M |
| March 31, 2018 | 9.677M |
| December 31, 2017 | 12.22M |
| September 30, 2017 | 14.45M |
| June 30, 2017 | 7.911M |
| March 31, 2017 | 2.341M |
| December 31, 2016 | 3.594M |
| September 30, 2016 | 5.047M |
| June 30, 2016 | 6.356M |
| March 31, 2016 | 1.155M |
| December 31, 2015 | 2.185M |
| September 30, 2015 | 3.032M |
| June 30, 2015 | 2.575M |
| March 31, 2015 | 3.413M |
| December 31, 2014 | 4.128M |
| September 30, 2014 | 4.497M |
| June 30, 2014 | 5.004M |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.25M |
| Shareholders Equity (Quarterly) | 18.50M |
| Debt to Equity Ratio | 0.2166 |
| Current Ratio | 0.1789 |
| Net Debt Paydown Yield | -0.52% |